These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7253803)

  • 1. Induction of behavioral supersensitivity to apomorphine by DFP treatment.
    Davis KL; Rosenberg GS
    Life Sci; 1981 Apr; 28(17):1953-9. PubMed ID: 7253803
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacologically induced behavioural supersensitivity to apomorphine.
    Tarsy D; Baldessarini RJ
    Nat New Biol; 1973 Oct; 245(148):262-3. PubMed ID: 4518989
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral effects of amfonelic acid in rats: a comparison with amphetamine and apomorphine.
    Jeste DV; Perlow MJ; Wyatt RJ; Stoff DM
    Commun Psychopharmacol; 1979; 3(1):41-7. PubMed ID: 38031
    [No Abstract]   [Full Text] [Related]  

  • 5. Different effects of apomorphine on climbing behavior and locomotor activity in three strains of mice.
    Cabib S; Puglisi-Allegra S
    Pharmacol Biochem Behav; 1985 Oct; 23(4):555-7. PubMed ID: 4070332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and neurochemical changes in rats dosed repeatedly with diisopropylfluorophosphate.
    Bushnell PJ; Padilla SS; Ward T; Pope CN; Olszyk VB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):741-50. PubMed ID: 1994004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynorphin A(1-13) modulates apomorphine-induced behaviors using multidimensional behavioral analyses in the mouse.
    Ukai M; Toyoshi T; Kameyama T
    Brain Res; 1989 Oct; 499(2):299-304. PubMed ID: 2572301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of two distinct behavioural responses by chronic treatment with ampomorphine.
    Kenny M; Lynch M; Leonard BE
    J Neurosci Res; 1980; 5(1):35-42. PubMed ID: 7189789
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in apomorphine pharmacodynamics following repeated treatment in 6-hydroxydopamine-lesioned rats.
    Gancher S; Mayer A; Youngman S
    Brain Res; 1996 Aug; 729(2):190-6. PubMed ID: 8876987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated apomorphine treatment causes behavioural supersensitivity and dopamine D2 receptor hyposensitivity.
    Bevan P
    Neurosci Lett; 1983 Feb; 35(2):185-9. PubMed ID: 6222273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic supersensitivity induced by denervation and chronic receptor blockade is additive.
    Staunton DA; Magistretti PJ; Koob GF; Shoemaker WJ; Bloom FE
    Nature; 1982 Sep; 299(5878):72-4. PubMed ID: 7110328
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in brain muscarinic acetylcholine receptors and behavioral responses to atropine and apomorphine in chronic atropine-treated rats.
    Takeyasu K; Uchida S; Noguchi Y; Fujita N; Saito K; Hata F; Yoshida H
    Life Sci; 1979 Aug; 25(7):585-92. PubMed ID: 502751
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diphasic action of apomorphine on motility of the rat. I. Dose-effect relationship in exploratory and basal motility].
    Vaccheri A; Dall'Olio R; Gandolfi O; Montanaro N
    Boll Soc Ital Biol Sper; 1981 Feb; 57(4):374-80. PubMed ID: 7236417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral effects of apomorphine during development of rats.
    Brus R; Herman ZS; Jamrozik Z
    Acta Physiol Pol; 1977; 28(3):243-6. PubMed ID: 561515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of L-histidine and chlorcyclizine on apomorphine-induced climbing behaviour and methamphetamine stereotypy in mice.
    Joshi VV; Balsara JJ; Jadhav JH; Chandorkar AG
    Eur J Pharmacol; 1981 Feb; 69(4):499-502. PubMed ID: 6113966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity.
    Creese I; Burt DR; Snyder SH
    Science; 1977 Aug; 197(4303):596-8. PubMed ID: 877576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse strain differences in apomorphine-induced behavior: an empirical and methodological study.
    Randall PK; Randall JS
    Behav Neurosci; 1986 Feb; 100(1):85-92. PubMed ID: 3954884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diphasic action of apomorphine on motility in the rat. II. Time aspects of the effect of a single dose].
    Vaccheri A; Gandolfi O; Dall'Olio R; Montanaro N
    Boll Soc Ital Biol Sper; 1981 Feb; 57(4):381-6. PubMed ID: 7236418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of acute behavioral toxicity of low doses of diisopropylfluorophosphate (DFP) in rats.
    Nieminen SA; Sirkka U; Lecklin A; Heikkinen O; Ylitalo P
    Methods Find Exp Clin Pharmacol; 1991 Nov; 13(9):617-23. PubMed ID: 1787768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.